Expression levels of adiponectin receptors and periodontitis

Journal of Periodontal Research

Volumn 45, Issue 2, 2010, Pages 296-300

  Yamaguchi, N ^a   Hamachi, T ^b   Kamio, N ^c   Akifusa, S ^c   Masuda, K ^a   Nakamura, Y ^a   Nonaka, K ^a   Maeda, K ^b   Hanazawa, S ^d   Yamashita, Y ^c  

^a Section of Pediatric Dentistry   (Japan)

^b Section of Periodontology   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

^d NIHON UNIVERSITY   (Japan)

Author keywords

Adiponectin receptor; Fibroblasts; Periodontitis; Tumor necrosis factor

Indexed keywords

ADIPONECTIN RECEPTOR; ADIPONECTIN RECEPTOR 1, MOUSE; ADIPONECTIN RECEPTOR 2, MOUSE; ADIPOR1 PROTEIN, HUMAN; ADIPOR2 PROTEIN, HUMAN; AUTACOID; CYTOKINE; TUMOR NECROSIS FACTOR ALPHA;

AGED; ANIMAL; ARTICLE; C57BL MOUSE; CELL CULTURE; CELL LINE; CHRONIC PERIODONTITIS; COMPARATIVE STUDY; DRUG EFFECT; FEMALE; FIBROBLAST; GINGIVA; GINGIVITIS; HUMAN; MALE; METABOLISM; MIDDLE AGED; MOUSE; PERIODONTAL POCKET; PERIODONTITIS;

AGED; ANIMALS; CELL LINE; CELLS, CULTURED; CHRONIC PERIODONTITIS; CYTOKINES; FEMALE; FIBROBLASTS; GINGIVA; GINGIVITIS; HUMANS; INFLAMMATION MEDIATORS; MALE; MICE; MICE, INBRED C57BL; MIDDLE AGED; PERIODONTAL POCKET; PERIODONTITIS; RECEPTORS, ADIPONECTIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77950241116     PISSN: 00223484     EISSN: 16000765     Source Type: Journal    
DOI: 10.1111/j.1600-0765.2009.01222.x     Document Type: Article

References (36)

1. Saito T, Shimazaki Y, Sakamoto M. Obesity and periodontitis. N Engl J Med 1998, 339:482-483.
2. Saito T, Shimazaki Y, Kiyohara Y. The severity of periodontal disease is associated with the development of glucose intolerance in non-diabetics: the Hisayama study. J Dent Res 2004, 83:485-490.
3. Dyck DJ, Heigenhauser GJ, Bruce GR. The role of adipokines as regulators of skeletal muscle fatty acid metabolism and insulin sensitivity. Acta Physiol 2006, 186:5-16.
4. Ouchi N, Walsh K. A novel role for adiponectin in the regulation of inflammation. Arterioscler Thromb Vasc Biol 2008, 28:1219-1221.
5. Page RC, Offenbacher S, Schroeder HE, Seymour GJ, Kornman KS. Advances in the pathogenesis of periodontitis: summary of developments, clinical implications and future directions. Periodontol 2000 1997, 14:216-248.
6. Rees TD. Periodontal management of the patient with diabetes mellitus. Periodontol 2000 2000, 23:63-72.
7. Arita Y, Kihara S, Ouchi N. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999, 257:79-83.
8. Hotta K, Funahashi T, Arita Y. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 2000, 20:1595-1599.
9. Saito T, Yamaguchi N, Shimazaki Y. Serum levels of resistin and adiponectin in women with periodontitis: Hisayama study. J Dent Res 2008, 87:319-322.
10. Fang X, Sweeney G. Mechanisms regulating energy metabolism by adiponectin in obesity and diabetes. Biochem Soc Trans 2006, 34:798-801.
11. Waki H, Yamauchi T, Kamon J. Generation of globular fragment of adiponectin by leukocyte elastase secreted by monocytic cell line THP-1. Endocrinology 2005, 146:790-796.
12. Yamauchi T, Kamon J, Ito Y. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 2003, 423:762-769.
13. Yamauchi T, Kamon J, Minokoshi Y. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 2002, 8:1288-1295.
14. Yamauchi T, Kamon J, Waki H. Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis. J Biol Chem 2003, 278:2461-2468.
15. Kadowaki T, Yamauchi T. Adiponectin and adiponectin receptors. Endocr Rev 2005, 26:439-451.
16. Ouchi N, Kihara S, Arita Y. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway. Circulation 2000, 102:1296-1301.
17. Ouchi N, Kobayashi H, Kihara S. Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in endothelial cells. J Biol Chem 2004, 279:1304-1309.
18. Yamaguchi N, Martinez Argueta JG, Masuhiro Y. Adiponectin inhibits Toll-like receptor family-induced signaling. FEBS Lett 2005, 579:6821-6826.
19. Yamaguchi N, Kukita T, Li YJ. Adiponectin inhibits osteoclast formation stimulated by lipopolysaccharide from Actinobacillus actinomycetemcomitans. FEMS Immunol Med Microbiol 2007, 49:28-34.
20. Yamaguchi N, Kukita T, Li YJ. Adiponectin inhibits induction of TNF-alpha/RANKL-stimulated NFATc1 via the AMPK signaling. FEBS Lett 2008, 582:451-456.
21. Yamaguchi N, Yamashita Y, Ikeda D, Koga T. Actinobacillus actinomycetemcomitans serotype b-specific polysaccharide antigen stimulates production of chemotactic factors and inflammatory cytokines by human monocytes. Infect Immun 1996, 64:2563-2570.
22. Bashir MM, Sharma MR, Werth VP. TNF-alpha production in the skin. Arch Dermatol Res 2009, 301:87-91.
23. Kobayashi M, Okada N, Okamatsu Y. Intracellular interleukin-1alpha production in human gingival fibroblasts is differentially regulated by various cytokines. J Dent Res 1999, 78:840-849.
24. Ruan H, Hacohen N, Golub TR, Van Parijs L, Lodish HF. Tumor necrosis factor-alpha suppresses adipocyte-specific genes and activates expression of preadipocyte genes in 3T3-L1 adipocytes: nuclear factor-kappaB activation by TNF-alpha is obligatory. Diabetes 2002, 51:1319-1336.
25. Kern PA, Di Gregorio GB, Lu T, Rassouli N, Ranganathan G. Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression. Diabetes 2003, 52:1779-1785.
26. Matsuzawa Y. Adiponectin: identification, physiology and clinical relevance in metabolic and vascular disease. Atheroscler Suppl 2005, 6:7-14.
27. Kita A, Yamasaki H, Kuwahara H. Identification of the promoter region required for human adiponectin gene transcription: Association with CCAAT/enhancer binding protein-beta and tumor necrosis factor-alpha. Biochem Biophys Res Commun 2005, 331:484-490.
28. Kim KY, Kim JK, Jeon JH, Yoon SR, Choi I, Yang Y. C-Jun N-terminal kinase is involved in the suppression of adiponectin expression by TNF-alpha in 3T3-L1 adipocytes. Biochem Biophys Res Commun 2005, 327:460-467.
29. Hirosumi J, Tuncman G, Chang L. A central role for JNK in obesity and insulin resistance. Nature 2002, 420:333-336.
30. Peraldi P, Hotamisligil GS, Buurman WA, White MF, Spiegelman BM. Tumor necrosis factor (TNF)-alpha inhibits insulin signaling through stimulation of the p55 TNF receptor and activation of sphingomyelinase. J Biol Chem 1996, 271:13018-13022.
31. Sethi JK, Xu H, Uysal KT, Wiesbrock SM, Scheja L, Hotamisligil GS. Characterisation of receptor-specific TNF alpha functions in adipocyte cell lines lacking type 1 and 2 TNF receptors. FEBS Lett 2000, 469:77-82.
32. Liu LS, Spelleken M, Rohrig K, Hauner H, Eckel J. Tumor necrosis factor-alpha acutely inhibits insulin signaling in human adipocytes: implication of the p80 tumor necrosis factor receptor. Diabetes 1998, 47:515-522.
33. Iwasaki A, Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat Immunol 2004, 5:987-995.
34. Tsuchida A, Yamauchi T, Ito Y. Insulin/Foxo1 pathway regulates expression levels of adiponectin receptors and adiponectin sensitivity. J Biol Chem 2004, 279:30817-30822.
35. Furugen R, Hayashida H, Yamaguchi N. The relationship between periodontal condition and serum levels of resistin and adiponectin in elderly Japanese. J Periodont Res 2008, 43:556-562.
36. Lee SW, Kim JH, Park MC, Park YB, Lee SK. Adiponectin mitigates the severity of arthritis in mice with collagen-induced arthritis. Scand J Rheumatol 2008, 37:260-268.